VisionPoint Advisory Group’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$263K Sell
1,253
-15
-1% -$3.33K 0.04% 374
2026
Q2
$267K Buy
1,268
+146
+13% +$31.3K 0.04% 391
2026
Q1
$248K Sell
1,122
-99
-8% -$24.2K 0.05% 376
2025
Q4
$310K Buy
1,221
+93
+8% +$23.4K 0.06% 296
2025
Q3
$279K Buy
1,128
+54
+5% +$12.9K 0.06% 305
2025
Q2
$258K Buy
+1,074
New +$250K 0.06% 299
2025
Q1
– Sell
-507
Closed -$103K – 298
2024
Q4
$103K Buy
507
+84
+20% +$18.4K 0.04% 231
2024
Q3
$103K Buy
423
+137
+48% +$32K 0.03% 222
2024
Q2
$62.8K Buy
286
+33
+13% +$7.17K 0.02% 247
2024
Q1
$56.9K Buy
253
+97
+62% +$21.9K 0.02% 251
2023
Q4
$34.3K Buy
+156
New +$33K 0.01% 301

Other funds holding STE

VisionPoint Advisory Group's STE Position: Q3 2026 in Review

VisionPoint Advisory Group reduced its Steris (STE) stake by 1.2% in Q3 2026, selling an estimated $3.33K and leaving 1,253 shares worth $263K. The position accounts for 0.04% of the portfolio, ranked #374.

VisionPoint Advisory Group first reported a position in STE in Q4 2023 and has held it in 11 quarters since. The position peaked at $310K in Q4 2025. 162 funds tracked by Wall St. Rank hold STE as of Q3 2026.

  • VisionPoint Advisory Group held 1,253 shares of Steris worth $263K as of Q3 2026.
  • VisionPoint Advisory Group sold 15 Steris shares in Q3 2026, an estimated $3.33K.
  • Steris made up 0.04% of VisionPoint Advisory Group's portfolio in Q3 2026, its #374 holding.
  • VisionPoint Advisory Group first reported a position in Steris in Q4 2023 and has held it in 11 quarters since.
  • VisionPoint Advisory Group's Steris position peaked at $310K in Q4 2025.
  • 162 funds tracked by Wall St. Rank held Steris as of Q3 2026.

Based on VisionPoint Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.